Actively Recruiting
A Phase 1 Study of ARC-001 in Participants Undergoing Third Molar Extraction
Led by Arcato Laboratories, Inc. · Updated on 2025-03-11
30
Participants Needed
1
Research Sites
48 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study will test the investigational product gel against placebo (which contains no active ingredient) to determine if it is safe after wisdom tooth extraction. The main questions the study will answer are: 1. How much of the investigational product is absorbed in the blood? 2. Are there side effects?
CONDITIONS
Official Title
A Phase 1 Study of ARC-001 in Participants Undergoing Third Molar Extraction
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Able to provide informed consent
- In generally good health
- BMI 18 to 38kg/m8
- Scheduled to undergo wisdom teeth extraction
You will not qualify if you...
- Serious medical condition
- Clinically significant abnormal lab values
- Blood donation in the last 60 days, or plasma donation in the last 7 days
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CenExel JBR
Salt Lake City, Utah, United States, 84107
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here